Financial statements L-Drog

Balance sheet of L-Drog

Company age:
Age:
15 y. 2 m. 7 d.
Share capital:
Share capital:
50 000 PLN

Balance sheet data of L-DROG

Year
2018
2019
2020
2021
2022
2023
Total assets 2 511 814,40 2 335 920,53 2 380 670,33 2 684 895,53 3 383 015,34 4 116 869,07
A. Fixed assets 699 697,89 933 482,30 970 642,12 1 515 160,13 1 674 332,87 1 436 261,60
B. Current assets 1 812 116,51 1 402 438,23 1 410 028,21 1 169 735,40 1 708 682,47 2 680 607,47
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 2 511 814,40 2 335 920,53 2 380 670,33 2 684 895,53 3 383 015,34 4 116 869,07
A. Equity 1 849 025,55 1 892 331,99 1 793 192,79 2 003 655,16 2 106 573,71 2 463 263,15
B. Liabilities and provisions for liabilities 662 788,85 443 588,54 587 477,54 681 240,37 1 276 441,63 1 653 605,92
I. Long-term liabilities 50 000,00 50 000,00 175 764,58 230 704,21 243 761,22 209 715,30
II. Short-term liabilities 612 788,85 393 588,54 411 712,96 450 536,16 1 032 680,41 1 279 553,09
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.